Legal & General Group PLC Sarepta Therapeutics, Inc. Transaction History
Legal & General Group PLC
- $368 Billion
- Q4 2024
A detailed history of Legal & General Group PLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 151,356 shares of SRPT stock, worth $11.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
151,356
Previous 152,213
0.56%
Holding current value
$11.6 Million
Previous $19 Million
3.2%
% of portfolio
0.01%
Previous 0.0%
Shares
31 transactions
Others Institutions Holding SRPT
# of Institutions
534Shares Held
85.3MCall Options Held
1.55MPut Options Held
1.35M-
Black Rock Inc. New York, NY10.3MShares$788 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.09MShares$693 Million0.02% of portfolio
-
Capital International Investors Los Angeles, CA8.7MShares$664 Million0.21% of portfolio
-
Janus Henderson Group PLC London, X04.33MShares$330 Million0.28% of portfolio
-
State Street Corp Boston, MA4.07MShares$311 Million0.02% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $6.68B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...